Sionna Therapeutics
Develops NBD1-stabilizing and complementary CFTR modulators for cystic fibrosis.
$5.89
After-hours close+0.03 (+0.44%)
At close$5.86(−3.30%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.63 | — | — |
| Aug 2026 | −$0.65 | −$0.66 | −1.5% |
| May 2026 | −$0.52 | −$0.60 | −15.4% |
| Mar 2026 | −$0.54 | −$0.46 | +14.7% |
| Nov 2025 | −$0.52 | −$0.46 | +11.5% |
The latest year is open to everyone — the 4 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.63 | — | — | — | — | — |
| Aug 6, 2026 | −$0.65 | −$0.66 | −1.5% | — | — | — |
| May 12, 2026 | −$0.52 | −$0.60 | −15.4% | — | — | — |
| Mar 2, 2026 | −$0.54 | −$0.46 | +14.7% | — | — | — |
| Nov 5, 2025 | −$0.52 | −$0.46 | +11.5% | — | — | — |
The latest year is open to everyone — the 4 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 27, 2024 | ||||||